
Prompt:
Identify the key legal concepts and principles related to the provided laws.
I will provide a context, which will follow the label "Context:"


Context: {'id': '164.314(b)(1)', 'data': '(1) Standard: Requirements for group health plans.  Except when the only electronic protected health information disclosed to a plan sponsor is disclosed pursuant to § 164.504(f)(1)(ii) or (iii), or as authorized under § 164.508, a group health plan must ensure that its plan documents provide that the plan sponsor will reasonably and appropriately safeguard electronic protected health information created, received, maintained, or transmitted to or by the plan sponsor on behalf of the group health plan. '}, {'id': 'Part164SubpartE', 'data': 'Subpart E—Privacy of Individually Identifiable Health Information'}, {'id': '164.502(a)(1)(iv)', 'data': '(iv) Except for uses and disclosures prohibited under § 164.502(a)(5)(i), pursuant to and in compliance with a valid authorization under § 164.508; '}, {'id': '164.502(b)(2)(iii)', 'data': '(iii) Uses or disclosures made pursuant to an authorization under § 164.508; '}, {'id': '164.504(f)(1)(i)', 'data': '(i) Except as provided under paragraph (f)(1)(ii) or (iii) of this section or as otherwise authorized under § 164.508, a group health plan, in order to disclose protected health information to the plan sponsor or to provide for or permit the disclosure of protected health information to the plan sponsor by a health insurance issuer or HMO with respect to the group health plan, must ensure that the plan documents restrict uses and disclosures of such information by the plan sponsor consistent with the requirements of this subpart. '}, {'id': '164.506(b)(2)', 'data': '(2) Consent, under paragraph (b) of this section, shall not be effective to permit a use or disclosure of protected health information when an authorization, under § 164.508, is required or when another condition must be met for such use or disclosure to be permissible under this subpart. '}, {'id': '164.508(a)', 'data': '(a) Standard: Authorizations for uses and disclosures —'}, {'id': '164.508(b)', 'data': '(b) Implementation specifications: General requirements —'}, {'id': '164.508(c)', 'data': '(c) Implementation specifications: Core elements and requirements —'}, {'id': '164.512(i)(1)(i)', 'data': '(i) Board approval of a waiver of authorization.  The covered entity obtains documentation that an alteration to or waiver, in whole or in part, of the individual authorization required by § 164.508 for use or disclosure of protected health information has been approved by either: '}, {'id': '164.514(f)(1)', 'data': '(1) Standard: Uses and disclosures for fundraising.  Subject to the conditions of paragraph (f)(2) of this section, a covered entity may use, or disclose to a business associate or to an institutionally related foundation, the following protected health information for the purpose of raising funds for its own benefit, without an authorization meeting the requirements of § 164.508: '}, {'id': '164.528(a)(1)(iv)', 'data': '(iv) Pursuant to an authorization as provided in § 164.508; '}, {'id': '164.532(a)', 'data': '(a) Standard: Effect of prior authorizations.  Notwithstanding §§ 164.508 and 164.512(i), a covered entity may use or disclose protected health information, consistent with paragraphs (b) and (c) of this section, pursuant to an authorization or other express legal permission obtained from an individual permitting the use or disclosure of protected health information, informed consent of the individual to participate in research, a waiver of informed consent by an IRB, or a waiver of authorization in accordance with § 164.512(i)(1)(i). '}, {'id': '164.532(b)', 'data': '(b) Implementation specification: Effect of prior authorization for purposes other than research.  Notwithstanding any provisions in § 164.508, a covered entity may use or disclose protected health information that it created or received prior to the applicable compliance date of this subpart pursuant to an authorization or other express legal permission obtained from an individual prior to the applicable compliance date of this subpart, provided that the authorization or other express legal permission specifically permits such use or disclosure and there is no agreed-to restriction in accordance with § 164.522(a). '}, {'id': '164.532(c)', 'data': '(c) Implementation specification: Effect of prior permission for research.  Notwithstanding any provisions in §§ 164.508 and 164.512(i), a covered entity may, to the extent allowed by one of the following permissions, use or disclose, for research, protected health information that it created or received either before or after the applicable compliance date of this subpart, provided that there is no agreed-to restriction in accordance with § 164.522(a), and the covered entity has obtained, prior to the applicable compliance date, either: '}, {'id': '164.532(c)(3)', 'data': '(3) A waiver, by an IRB, of informed consent for the research, in accordance with 7 CFR 1c.116(d), 10 CFR 745.116(d), 14 CFR 1230.116(d), 15 CFR 27.116(d), 16 CFR 1028.116(d), 21 CFR 50.24, 22 CFR 225.116(d), 24 CFR 60.116(d), 28 CFR 46.116(d), 32 CFR 219.116(d), 34 CFR 97.116(d), 38 CFR 16.116(d), 40 CFR 26.116(d), 45 CFR 46.116(d), 45 CFR 690.116(d), or 49 CFR 11.116(d), provided that a covered entity must obtain authorization in accordance with § 164.508 if, after the compliance date, informed consent is sought from an individual participating in the research; or '}, {'id': '45 CFR 164.512', 'data': 'None'}, {'id': 'Part164SubpartE', 'data': 'Subpart E—Privacy of Individually Identifiable Health Information'}, {'id': '164.508(a)', 'data': '(a) Standard: Authorizations for uses and disclosures —'}, {'id': '164.508(b)', 'data': '(b) Implementation specifications: General requirements —'}, {'id': '164.508(c)', 'data': '(c) Implementation specifications: Core elements and requirements —'}, {'id': '164.314(b)(1)', 'data': '(1) Standard: Requirements for group health plans.  Except when the only electronic protected health information disclosed to a plan sponsor is disclosed pursuant to § 164.504(f)(1)(ii) or (iii), or as authorized under § 164.508, a group health plan must ensure that its plan documents provide that the plan sponsor will reasonably and appropriately safeguard electronic protected health information created, received, maintained, or transmitted to or by the plan sponsor on behalf of the group health plan. '}, {'id': '164.502(a)(1)(iv)', 'data': '(iv) Except for uses and disclosures prohibited under § 164.502(a)(5)(i), pursuant to and in compliance with a valid authorization under § 164.508; '}, {'id': '164.502(b)(2)(iii)', 'data': '(iii) Uses or disclosures made pursuant to an authorization under § 164.508; '}, {'id': '164.504(f)(1)(i)', 'data': '(i) Except as provided under paragraph (f)(1)(ii) or (iii) of this section or as otherwise authorized under § 164.508, a group health plan, in order to disclose protected health information to the plan sponsor or to provide for or permit the disclosure of protected health information to the plan sponsor by a health insurance issuer or HMO with respect to the group health plan, must ensure that the plan documents restrict uses and disclosures of such information by the plan sponsor consistent with the requirements of this subpart. '}, {'id': '164.506(b)(2)', 'data': '(2) Consent, under paragraph (b) of this section, shall not be effective to permit a use or disclosure of protected health information when an authorization, under § 164.508, is required or when another condition must be met for such use or disclosure to be permissible under this subpart. '}, {'id': '45 CFR 164.512', 'data': 'None'}, {'id': '164.512(i)(1)(i)', 'data': '(i) Board approval of a waiver of authorization.  The covered entity obtains documentation that an alteration to or waiver, in whole or in part, of the individual authorization required by § 164.508 for use or disclosure of protected health information has been approved by either: '}, {'id': '164.514(f)(1)', 'data': '(1) Standard: Uses and disclosures for fundraising.  Subject to the conditions of paragraph (f)(2) of this section, a covered entity may use, or disclose to a business associate or to an institutionally related foundation, the following protected health information for the purpose of raising funds for its own benefit, without an authorization meeting the requirements of § 164.508: '}, {'id': '164.528(a)(1)(iv)', 'data': '(iv) Pursuant to an authorization as provided in § 164.508; '}, {'id': '164.532(a)', 'data': '(a) Standard: Effect of prior authorizations.  Notwithstanding §§ 164.508 and 164.512(i), a covered entity may use or disclose protected health information, consistent with paragraphs (b) and (c) of this section, pursuant to an authorization or other express legal permission obtained from an individual permitting the use or disclosure of protected health information, informed consent of the individual to participate in research, a waiver of informed consent by an IRB, or a waiver of authorization in accordance with § 164.512(i)(1)(i). '}, {'id': '164.532(b)', 'data': '(b) Implementation specification: Effect of prior authorization for purposes other than research.  Notwithstanding any provisions in § 164.508, a covered entity may use or disclose protected health information that it created or received prior to the applicable compliance date of this subpart pursuant to an authorization or other express legal permission obtained from an individual prior to the applicable compliance date of this subpart, provided that the authorization or other express legal permission specifically permits such use or disclosure and there is no agreed-to restriction in accordance with § 164.522(a). '}, {'id': '164.532(c)', 'data': '(c) Implementation specification: Effect of prior permission for research.  Notwithstanding any provisions in §§ 164.508 and 164.512(i), a covered entity may, to the extent allowed by one of the following permissions, use or disclose, for research, protected health information that it created or received either before or after the applicable compliance date of this subpart, provided that there is no agreed-to restriction in accordance with § 164.522(a), and the covered entity has obtained, prior to the applicable compliance date, either: '}, {'id': '164.532(c)(3)', 'data': '(3) A waiver, by an IRB, of informed consent for the research, in accordance with 7 CFR 1c.116(d), 10 CFR 745.116(d), 14 CFR 1230.116(d), 15 CFR 27.116(d), 16 CFR 1028.116(d), 21 CFR 50.24, 22 CFR 225.116(d), 24 CFR 60.116(d), 28 CFR 46.116(d), 32 CFR 219.116(d), 34 CFR 97.116(d), 38 CFR 16.116(d), 40 CFR 26.116(d), 45 CFR 46.116(d), 45 CFR 690.116(d), or 49 CFR 11.116(d), provided that a covered entity must obtain authorization in accordance with § 164.508 if, after the compliance date, informed consent is sought from an individual participating in the research; or '}


Output Struct:
{ 
	"key legal concepts": ["explanation of concept 1", "explanation of concept 2", ...], 
	"key legal principles": ["explanation of principle 1", "explanation of principle 2", ...],
	"application scenarios": ["something", "something"],
	"relationship to overall document argument": ["something", "something"]
}


You should focus solely on explaining THIS LAW within the given context:
THIS LAW:
{'id': '164.508', 'data': '§ 164.508 Uses and disclosures for which an authorization is required.'}
You may now respond.
